Methadone and Pregnancy: Risks and Safer Alternatives
Methadone maintenance therapy (MMT) is the standard of care for opioid use disorder (OUD) in pregnancy — not contraindicated. Abrupt cessation causes withdrawal, risking preterm labor, fetal distress, miscarriage.
Evidence-Based Guidance
- Methadone: Full μ-agonist; stabilizes maternal/fetal opioid levels; reduces illicit use, improves prenatal care engagement. Dose often needs increase in 3rd trimester (increased clearance).
- Buprenorphine: Partial agonist; alternative with lower neonatal abstinence syndrome (NAS) severity, less QT prolongation risk. Monotherapy (without naloxone) preferred.
- NAS: Expected with both; treatable with non-pharmacologic care ± morphine. Breastfeeding encouraged (low milk levels).
MMT/buprenorphine + comprehensive prenatal care = best outcomes. Do not stop without medical supervision. The original statement is outdated and potentially harmful.
Pregnancy & Health - Related Articles
- 30 Days Past Ovulation (DPO): Why It's Not Possible and What to Do If You Suspect Pregnancy
- Early Signs of Pregnancy with Twins: What to Watch For
- Pregnancy Concerns: Why You Should Consult a Healthcare Professional
- Clorox (Sodium Hypochlorite) Use During Pregnancy: Safety Data and Precautions
- Early Pregnancy and Premarital Sex in College Students: Causes & Prevention
- Spotting at 7 Weeks Pregnant: Causes and When to Call Your Provider
- Understanding Bleeding During Pregnancy: Causes & Flow Patterns
